Skip to main content

Affordability Check

How to afford YARTEMLEA

Generic name: narsoplimab

Pick how you're covered. We'll show you the cheapest legitimate way to get YARTEMLEA — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.

How are you covered for prescriptions?

Pick the one that fits you. We'll show you the cheapest way to get this drug.

Pick an option above to see your specific path.

Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.

About YARTEMLEA and its cost

What is this medication? Coartem is a prescription medication primarily used for the treatment of acute and uncomplicated malaria infections caused by the Plasmodium falciparum parasite. It is typically formulated as a combination therapy containing artemether and lumefantrine, which are two active ingredients that work together to eliminate malaria parasites within the red blood cells. This combination is particularly effective in regions where the parasite has become resistant to other standard antimalarial treatments, making it a critical option for restoring the health of infected individuals. The medication is generally administered orally and should be taken with a meal that contains fat, such as milk or food, to ensure that the active ingredients are properly absorbed by the body. It is important for patients to complete the entire prescribed course of the medication even if they begin to feel better, as this ensures that the infection is fully cleared and helps prevent the recurrence of symptoms. Patients should discuss their medical history and any potential side effects like dizziness or loss of appetite with a healthcare professional before starting the treatment.

YARTEMLEA is made by a pharmaceutical manufacturer. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.

Common questions

What's the cheapest way to afford YARTEMLEA?

It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.

Can I use a copay card with Medicare for YARTEMLEA?

No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But the manufacturer has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.

Does my Medicare Part D plan cover YARTEMLEA?

Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.

How long does a Patient Assistance Program take?

Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.

What if I have a high-deductible plan?

For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.

Are there charity grants for Wet Age-Related Macular Degeneration?

Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.

More about YARTEMLEA